Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hubert Buyse"'
Publikováno v:
Vaccine. 38(40)
Background Vaccination of pregnant women against hepatitis A virus (HAV) or hepatitis B virus (HBV) may benefit the mother and the fetus but is not routinely recommended. However, the risk associated with vaccination should be weighed against the ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a97fe1221d94a4bd8cf7ac75ea3820
https://pubmed.ncbi.nlm.nih.gov/32741674
https://pubmed.ncbi.nlm.nih.gov/32741674
Autor:
Peter Basile, Hubert Buyse, Naveen Karkada, Nicolas Praet, Edouard Ledent, Gaëlle Nachbaur, Hugo Arlegui
Publikováno v:
Biodrugs
Introduction Two vaccines against rotavirus gastroenteritis (RVGE) in young children, Rotarix and RotaTeq, have been available in Europe since 2006. Vaccination against rotaviruses significantly reduces the burden of RVGE, but it is also associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b26f6e88b67fbae20808da99d569da7
https://doi.org/10.1007/s40259-018-0273-6
https://doi.org/10.1007/s40259-018-0273-6
Autor:
Hubert Buyse, Vincent Bauchau, Katsiaryna Holl, Lionel Van Holle, Keiji Sugiyama, Olivia Mahaux
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose RotarixTM was launched in November 2011 in Japan to prevent rotavirus gastroenteritis. Some studies suggest that RotarixTM may have a temporal association with a risk of intussusception (IS). We assessed a possible association between IS and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc47cfec6d795a8b90adb6850731fca
http://europepmc.org/articles/PMC4736691
http://europepmc.org/articles/PMC4736691
Publikováno v:
Human Vaccines & Immunotherapeutics. 10:19-24
An integrated analysis of safety and reactogenicity data was undertaken for 28 randomized, placebo-controlled, double-blind Phase II and III trials (DBRCTs) of the oral live-attenuated human rotavirus vaccine, Rotarix™ (GlaxoSmithKline Vaccines). H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dff016d7037900e34adddd09d503c98c
https://doi.org/10.4161/hv.26476
https://doi.org/10.4161/hv.26476
Autor:
Dominique Rosillon, Sandrine Fontaine, Vincent Bauchau, François Haguinet, Marie-Noëlle Marenne, Corinne Willame, Hubert Buyse, Laurence Baril, Catherine Cohet
Publikováno v:
Vaccine. 35(23)
Post-authorisation safety studies (PASS) of vaccines assess or quantify the risk of adverse events following immunisation that were not identified or could not be estimated pre-licensure. The aim of this perspective paper is to describe the authors'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ae4d267f90fd10b123d8659bb640cc
https://pubmed.ncbi.nlm.nih.gov/28465097
https://pubmed.ncbi.nlm.nih.gov/28465097
Autor:
Hubert Buyse, Keiji Sugiyama, Michael Mckenna, Edouard Ledent, Katsiaryna Holl, Alfons Lieftucht
Publikováno v:
Drug Safety
Introduction Rotarix™, GSK’s live attenuated rotavirus vaccine, was introduced in Japan in 2011. A recent trend in reduction of rotavirus gastroenteritis (RVGE) due to this vaccine was described. However, an observed/expected analysis showed a te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e463d619bb1d7ae4ced1c9fa3d08a44
https://pubmed.ncbi.nlm.nih.gov/26748506
https://pubmed.ncbi.nlm.nih.gov/26748506
Autor:
Hubert Buyse, Cheryl Enger, Crystal N. Holick, Remon Abu-Elyazeed, David D. Dore, Nicolas Praet, Kathleen Skerry, Dominique Rosillon, Scott C. Quinlan, Veena Hoffman, Daina B. Esposito, Stéphanie Wéry, M. C. Doherty
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::130b2f98d1c582670c693588c4e926fe
https://doi.org/10.1093/ofid/ofw172.660
https://doi.org/10.1093/ofid/ofw172.660
Autor:
Su-Peing Ng, F. Raúl Velázquez, Thomas Breuer, Dominique Rosillon, Leonard R. Friedland, Hubert Buyse
Publikováno v:
The Pediatric infectious disease journal. 34(7)
Postlicensure surveillance studies suggest a small temporal increase in the risk for intussusception with both currently available rotavirus vaccines (RV1; Rotarix, GSK and RV5; RotaTeq, MerckCo., Inc.). This meta-analysis was undertaken to provide a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6547d3ab0c51715e39018ad1f0876f
https://pubmed.ncbi.nlm.nih.gov/26069948
https://pubmed.ncbi.nlm.nih.gov/26069948